A Retrospective Observational Study to describe the Effectiveness and Safety of Vedolizumab With or Without Budesonide Induction Therapy Among Patients with Moderate to Severe Crohn’s Disease (Vedo-BuDy)

24/04/2019
02/07/2024
EU PAS number:
EUPAS28791
Study
Finalised
Documents
Study protocol
Study results
Study results
English (194.39 KB - PDF) View document
Study report
Other information